Literature DB >> 10729841

Increased defibrillation threshold with right-sided active pectoral can.

P R Roberts1, S Allen, T Betts, J M Morgan, J F Urban, T Whitman, D E Euler, M J Kallok.   

Abstract

UNLABELLED: The aim of this study was to identify the optimal position on the chest wall to place an implant able cardioverter defibrillator in a two-electrode system, consisting of a right ventricular electrode and active can. METHODS AND
RESULTS: Defibrillation thresholds (DFT) were measured in 10 anaesthetised pigs (weight 33-45 kg). An Angeflextrade mark lead was introduced transvenously to the right ventricular apex. The test-can (43 cc) was implanted submuscularly in each of four locations: left pectoral (LP), right pectoral (RP), left lateral (LL) and apex (A). The sequence in which the four locations were tested was randomized. Ventricular fibrillation (VF) was induced using 60 Hz alternating current. Rectangular biphasic shocks were delivered 10 seconds after VF induction. The DFT was measured using a modified four-reversal binary search. The results of the four configurations were: LP, 14.6+/- 4.0 J; RP, 18.8+/- 4.2 J; LL, 14.7+/- 4.1 J; A, 14.9+/- 3.1 J. Repeated measures analysis of variance showed that the DFT of RP was significantly higher than LP, LL and A (p < 0.05).
CONCLUSIONS: Implanting an active can in the RP position increases the DFT by 29% compared to LP, LL and A sites. The can position on the left thorax does not appear to have a significant influence on DFT.

Entities:  

Mesh:

Year:  2000        PMID: 10729841     DOI: 10.1023/a:1009882016469

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  Right side implant of the unipolar single lead defibrillation system.

Authors:  A Natale; J Sra; M J Geiger; K Newby; M Akhtar; A Pacifico
Journal:  Pacing Clin Electrophysiol       Date:  1997-08       Impact factor: 1.976

2.  Three-dimensional potential gradient fields generated by intracardiac catheter and cutaneous patch electrodes.

Authors:  A S Tang; P D Wolf; Y Afework; W M Smith; R E Ideker
Journal:  Circulation       Date:  1992-05       Impact factor: 29.690

3.  Elevated defibrillation threshold when right-sided venous access is used for nonthoracotomy implantable defibrillator lead implantation. The Endotak Investigators.

Authors:  A E Epstein; G N Kay; V J Plumb; L Voshage-Stahl; M L Hull
Journal:  J Cardiovasc Electrophysiol       Date:  1995-11

4.  Comparison of right- and left-sided pectoral implantation parameters with the Jewel active can cardiodefibrillator. The World Wide Jewel Investigators.

Authors:  G C Flaker; R Tummala; J Wilson
Journal:  Pacing Clin Electrophysiol       Date:  1998-02       Impact factor: 1.976

5.  Implantation of active can implantable defibrillators in the right pectoral region.

Authors:  S M Jensen; A Pietersen; X Chen
Journal:  Pacing Clin Electrophysiol       Date:  1998-02       Impact factor: 1.976

6.  The defibrillation threshold: a comparison of anesthetics and measurement methods.

Authors:  R M Gill; R J Sweeney; P R Reid
Journal:  Pacing Clin Electrophysiol       Date:  1993-04       Impact factor: 1.976

7.  The potential gradient field created by epicardial defibrillation electrodes in dogs.

Authors:  P S Chen; P D Wolf; F J Claydon; E G Dixon; H J Vidaillet; N D Danieley; T C Pilkington; R E Ideker
Journal:  Circulation       Date:  1986-09       Impact factor: 29.690

8.  Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location.

Authors:  S Saksena; P DeGroot; R B Krol; R Raju; P Mathew; R Mehra
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690

9.  Ventricular defibrillation with myocardial electrodes in the dog, calf, pony, and pig.

Authors:  J H Gold; J C Schuder; H Stoeckle
Journal:  Med Instrum       Date:  1980 Jan-Feb

10.  Anatomy of the pig heart: comparisons with normal human cardiac structure.

Authors:  S J Crick; M N Sheppard; S Y Ho; L Gebstein; R H Anderson
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

  10 in total
  8 in total

1.  Vigilance and the technologic promise of the third millennium.

Authors:  S Saksena
Journal:  J Interv Card Electrophysiol       Date:  2000-04       Impact factor: 1.900

2.  Evaluation of defibrillation safety margin in modern implantable cardioverter defibrillators after administration of amiodarone.

Authors:  Julia Köbe; Florian Reinke; Dirk G Dechering; Günter Breithardt; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2011-11-05       Impact factor: 5.460

3.  ICD implantation without intraoperative testing does not increase the rate of system modifications and does not impair defibrillation efficacy tested in follow-up.

Authors:  Dirk Bastian; Stefan Kracker; Matthias Pauschinger; Konrad Göhl
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-06-07

4.  Additional coronary sinus defibrillation lead with a right pectoral ICD and high DFT : a case report.

Authors:  M Strauss; T Kleemann; U Weisse; F-U Sack; R Zahn
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2011-04-10

5.  How to Manage a High Defibrillation Threshold in ICD Patients: and Does it Really Matter?

Authors:  Maria Vittoria Matassini; Jeff S Healey
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-08

6.  Fabry cardiomyopathy presenting with a high defibrillation threshold: A short case report.

Authors:  Takashi Kanda; Masaharu Masuda; Akihiro Sunaga; Masashi Fujita; Osamu Iida; Shin Okamoto; Takayuki Ishihara; Kiyonori Nanto; Tatsuya Shiraki; Fusako Sera; Masaaki Uematsu
Journal:  J Arrhythm       Date:  2014-12-02

7.  Cardiac defibrillator implantation via persistent left superior vena cava - sometimes this approach is facile. A case report.

Authors:  Andrzej Bissinger; Fardokht Bahadori-Esfahani; Andrzej Lubiński
Journal:  Arch Med Sci       Date:  2011-03-08       Impact factor: 3.318

8.  Significance of intraoperative testing in right-sided implantable cardioverter-defibrillators.

Authors:  Andreas Keyser; Michael K Hilker; Ekrem Ucer; Sigrid Wittmann; Christof Schmid; Claudius Diez
Journal:  J Cardiothorac Surg       Date:  2013-04-11       Impact factor: 1.637

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.